Pathogenicity of Staphylococcus aureus mutants in general and local infections.
D000818:Animals; D001426:Bacterial Proteins / Q000032:analysis; D001431:Bacteriological Techniques; D001434:Bacteriophage Typing; D003030:Coagulase / Q000032:analysis; D003470:Culture Media; D005260:Female; D005341:Fibrinolysin / Q000032:analysis; D006168:Guinea Pigs; D006460:Hemolysin Proteins / Q000032:analysis; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007928:Lethal Dose 50; D008297:Male; D008353:Mannitol / Q000032:analysis; D008722:Methods; D051379:Mice; D009154:Mutation; D009696:Nucleic Acids; D013203:Staphylococcal Infections; D013210:Staphylococcus / Q000032:analysis / Q000201:enzymology / Q000254:growth & development / Q000472:pathogenicity*; D013997:Time Factors
D001426:Bacterial Proteins; D003030:Coagulase; D003470:Culture Media; D006460:Hemolysin Proteins; D009696:Nucleic Acids; D008353:Mannitol; D005341:Fibrinolysin